1. Harmer A, Xiao Y, Missoni E, Tediosi F. ‘BRICS without straw’? A systematic literature review of newly emerging economies’ influence in global health. Global Health 2013; 9: 15. doi: 10.1186/1744-8603-9-15
2. Harmer A, Folayinka D, Lesong C. The BRICS: what is their contribution to global health? A Global Village 2013; 9: 34-7.
3. Hau M, Scott J, Hulme D. Beyond the BRICs: alternative strategies of influence in the global politics of development. Eur J Dev Res 2012; 24: 187-204. doi: 10.1057/ejdr.2012.6
4. Petrie D, Tang KK. Relative health performance in BRICS over the past 20 years: the winners and losers. Bull World Health Organ 2014; 92: 396-404. doi: 10.2471/blt.13.132480
5. World Economic and Financial Surveys. World Economic Outlook Database [internet]. [cited 2013 November 5].Available from: http://www.imf.org/external/pubs/ft/weo/2013/01/weodata/index.aspx
6. Passarelli C, Pimenta C, Danishevskiy K, Singh S, Yan G, Kaufman J. Shifting paradigm: How the BRICS are reshaping global health and development, Global Health Strategies initiatives (GHSi) [internet]. [cited 2013 October 21].Available from: http://www.eldis.org/go/display&t
7. Harmer A, Buse K. The BRICS – a paradigm shift in global health? Contemporary Politics 2014; 20: 127-45. doi: 10.1080/13569775.2014.907988
8. Kirton J, Kulik J, Bracht C. Generating global health governance through BRICS summitry. Contemporary Politics 2014; 20: 146-62. doi: 10.1080/13569775.2014.907990
9. Rao SG, Thomas D, Zachariah S, Kannan MS, Alvarez-Uria G. Comparison of essential drug list in a rural secondary care hospital in south India with Indian & World Health Organization list 2011. Indian J Physiol Pharmacol 2012; 56: 375-81.
10. Chen W, Tang S, Sun J, Ross-Degnan D, Wagner AK. Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces. BMC Health Ser Res 2010; 10: 211. doi: 10.1186/1472-6963-10-211
11. Kaddar M, Milstien J, Schmitt S. Impact of BRICS’ investment in vaccine development on the global vaccine market. Bull World Health Organ 2014; 92: 436-46. doi: 10.2471/blt.13.133298
12. Sáenz TW, Souza-Paula MC, Melon CM, Ray M, Thorsteinsdóttir H. Setting a southern course: Brazil’s south-south collaboration in health biotech. In: Thorsteinsdóttir H, editor. South-South Collaboration in Health Biotechnology: Growing Partnerships amongst Developing Countries. Ottawa: IDRC & Academic Foundation; 2012. p. 99-121.
13. Chaturvedi S, Thorsteinsdóttir H. BRICS and south-south cooperation in medicine: Emerging trends in research and entrepreneurial collaborations[internet].2012.[cited 2013 July 10]. Available from:http://www.ris.org.in/images/RIS_images/pdf/dp177_pap.pdf
14. Aly S, Madkour MA, Maram H, Adly N. Learning through collaborations: Egypt’s south-south health biotechnology collaboration. In: Thorsteinsdóttir H, editor. South-south collaboration in health biotechnology: Growing partnerships amongst developing countries. Ottawa: IDRC & Academic Foundation; 2012. p. 153-72.
15. Access Campaign. MSF calls on BRICS countries to prioritize health and access to medical innovation [internet]. [cited 2014 August 18]. Available from: http://www.msfaccess.org/
16. Liao, K. BRICS Nations Team to Strengthen Health Sector [internet]. [cited 2014 January 20]. Available from:
17. [No author listed]. Special theme: BRICS and the global health 2014. Bull World Health Organ 2014; 92: 385. doi: 10.2471/BLT.14.000614
18. Timmermans K. Ensuring access to medicines in 2005 and beyond [internet].[cited 2013 July 25]. Available from: http://www.tansey.org.uk/docs/neg-health-intro.pdf
19. Rovira, J. Creating and promoting domestic drug manufacturing capacities: A solution for developing countries [internet].2006. [cited 2013 November 25]. Available from: https://www.unido.org/fileadmin/user_media/
20. Yu P. Access to medicines, BRICS alliances, and collective action. Am J Law Med 2008; 34: 345-94.
21. Laidi Z. BRICS: Sovereignty power and weakness. Int Politics 2012; 49: 614-32. doi: 10.1057/ip.2012.17
22. Yu PK. Access to medicines, BRICS alliances, and collective action. Am J Law Med 2008; 34: 345-94.
23. World Health Organization (WHO). Global Health Observatory (GHO) [internet].[cited 2013 November 25]. Available from: http://www.who.int/gho/countries/bra/en/
24. Ross C. Building BRICs: Pharma’s key emerging markets are becoming giants [internet].[cited 2013 August 5]. Available from: http://www.pmlive.com
25. Ernst & Young’s 2012 attractiveness survey in Russia 2012 [internet].[cited 2012 November 5]. Available from: http://emergingmarkets.ey.com/wp-content/uploads/downloads/2012/09/RAS_2012_2012_09.06_FINAL.pdf
26. United Nations Industrial Development Organization (UNIDO). Italy funds AIDS project in South Africa [internet].[cited 2013 June 29]. Available from: http://www.manufacturingchemist.com/
27. MBendi. Pharmaceutical and Medicine Manufacturing in South Africa [internet].[cited 2013 November 13]. Available from: http://www.mbendi.com/indy/chem/phrm/af/sa/p0005.htm
28. Amuasi JH. Technology transfer and local manufacturing of pharmaceuticals: The South African case [internet]. [cited 2013 December 9]. Available from: http://ictsd.org/downloads/2009/12/amuasi-paper-edited.pdf
29. Maloney C, Segal N. The Growth Potential of the Pharmaceuticals Sector in South Africa. South Africa, Johannesburg: Genesis Analytics (Pty) Ltd; 2007.
30. Almeida C, Pires de Campos R, Buss P, Ferreira JR, Fonseca LE. Brazil’s conception of south-south “structural cooperation” in health. Global Forum Update on Research for Health 2010;4: 23-32.
31. Health Cooperation: Brazilian International Health Activities Bulletin [internet].2010. Available from: http://portal.saude.gov.br/portal/arquivos/pdf/Boletim_AISA_ING_alta.pdf
32. Chaudhuri S, Mackintosh M, Mujinja PG. Indian generics producers, access to essential medicines and local production in Africa: an argument with reference to Tanzania. European Journal of Development Research 2010; 22: 451-68. doi: 10.1057/ejdr.2010.27
33. Serruya SJ, Guimarães R, de Albuquerque IO, Morel CM. Research and innovation in Brazil: The institutional role of the ministry of health. Global Forum Update on Research for Health 2008;5: 24-7.
34. Novaratis. Novartis completes acquisition of majority stake in Zhejiang Tianyuan expanding vaccines presence in China [internet].2014. [cited 2014 February 2]. Available from: http://www.reuters.com/article/2011/03/22/idUS50620+22-Mar-2011+HUG20110322
35. KPMG. China’s Pharmaceutical Industry – Poised for the giant leap [internet]. [cited 2013 March 15]. Available from: http://www.kpmg.com/
36. Wassener B. In China, Strong Debut for Supplier of Heparin. The New York Times [serial on the internet.2010. Available from: http://www.nytimes.com/2010/05/07/business/global/07drug.html?_r=0
37. Jiangsu Hengrui [internet].2013. Available from: http://www.hrs.com.cn/english/
38. Kresge N. China’s Thirst for New Diabetes Drugs Threatens Bayer’s Lead [internet].2011. Available from: http://www.bloomberg.com/
39. Techpool [home page on the internet].2013. Available from: http://www.techpool.com.cn/index_en.html
40. Frew SE, Kettler HE, Singer PA. The Indian and Chinese Health Biotechnology Industries: Potential Champions Of Global Health? Health Aff (Millwood) 2008; 27: 1029-41. doi: 10.1377/hlthaff.27.4.1029
41. Burki TK. BRICS nations tackle non-communicable diseases. Lancet Oncol 2012; 13: 451. doi: 10.1016/s1470-2045(12)70151-1
42. Elbeshbishi AN. TRIPS and public health: What should African countries do? ATPC Work in progress No. 49. Addis Ababa: Economic Commission for Africa; 2007.
43. Yusuf S, Nabeshima K, Perkins DH. China and India Reshape Global Industrial Geography. In: Winters A, Yusuf S, editors. Dancing with Giants-China, India, and the Global Economy. Washington and Singapore: The World Bank and the Institute of Policy Studies; 2007. p. 35-66.
44. World Health Organization (WHO). Public health, innovation and intellectual property rights. [internet].2006. Available from: http://www.who.int/intellectualproperty/report/en/
45. Rao KD, Petrosyan V, Araujo E C, McIntyre D. Progress towards universal health coverage in BRICS: translating economic growth into better health. Bull World Health Organ 2014; 92: 429-35. doi: 10.2471/blt.13.127951
46. Zandi L. Technology Transfer and Business Partnerships in BRICS: Development, Integration and Industrialization. Mediterranean Journal of Social Sciences 2014; 5: 284-93. doi: 10.5901/mjss.2014.v5n7p284
47. Littlejohns P. Banking on the BRICS for health? Lancet 2013; 381: 1158. doi: 10.1016/s0140-6736(13)60781-3
48. Shamik D. At last, some good news about the world economy. Management Today 2012; 7: 26-7.
49. Tseng CY. Technological Innovations in the BRIC Economies. Research Technology Management 2009; 52: 29-35.
50. Council on Health Research for Development (COHRED) and New Partnership for Africa’s Development (NEPAD). Strengthening pharmaceutical innovation in Africa: Designing strategies for national pharmaceutical innovation: Choice for decision makers and countries [internet].[cited 2013 July 21]. Available from: http://www.policycures.org/downloads/COHRED-NEPAD_Strengthening_Pharmaceutical_Innovation_AfricaREPORT.pdf